Cytosorbents (CTSO) Non-Current Debt (2016 - 2026)

Cytosorbents (CTSO) has 10 years of Non-Current Debt data on file, last reported at $10.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 27.31% year-over-year to $10.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.3 million (down 27.31% YoY), and the FY2025 full-year result was $16.7 million, up 19.08% from the prior year.
• Non-Current Debt for Q1 2026 stood at $10.3 million, down from $16.7 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $16.7 million in Q4 2025 and bottomed at $1.9 million in Q1 2024.
• The 5-year median for Non-Current Debt is $13.7 million (2024), against an average of $10.0 million.
• The widest annual swing landed in 2023, when Non-Current Debt slumped 49.14%; it then jumped 635.61% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $5.0 million in 2022, then plunged by 49.14% to $2.5 million in 2023, then surged by 450.4% to $14.0 million in 2024, then advanced by 19.08% to $16.7 million in 2025, then slumped by 38.12% to $10.3 million in 2026.
• The last three Non-Current Debt figures came in at $10.3 million (Q1 2026), $16.7 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.

Peer Comparison